VER 01 randomized trial results in chronic low back pain
The VER-01 trial tested a chemically standardized cannabis extract in CLBP and showed consistent benefit with tolerability.
Pain medicine • Chronic low back pain • Reports
This site is intended for healthcare professionals and relevant decision makers.
Pain medicine
Standardized cannabis extracts challenge policy and payer assumptions in chronic pain
The VER-01 trial forces health systems, regulators, and payers to reconsider whether standardized cannabis extracts belong in mainstream chronic pain care.
Pain medicine • Chronic low back pain • Perspectives
Hospitals can scale VER 01 safely if they build a narrow pathway and measure weekly
The VER-01 trial shows a standardized cannabis extract can improve pain outcomes in CLBP. Systems can translate this only with narrow eligibility and stewardship.
Pain medicine • Chronic low back pain • Insights
Cannabis extract reduces chronic low back pain in a large randomized trial
A multicenter phase 3 trial in Nature Medicine demonstrated that a standardized full-spectrum cannabis extract (VER-01) reduced pain intensity and neuropathic symptoms in chronic low back pain.
Pain medicine • Chronic low back pain • Clinical